How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?

The efficacy and safety of the fixed-ratio combination of insulin degludec (degludec) and liraglutide (IDegLira) were confirmed in the DUAL clinical trial program, in which IDegLira demonstrated superior or noninferior glycemic control over comparators in addition to its low risks of hypoglycemia an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibaldi, Joseph, Mercado, Max E., Strong, Jodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566936/
https://www.ncbi.nlm.nih.gov/pubmed/33132503
http://dx.doi.org/10.2337/cd20-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566936/
https://www.ncbi.nlm.nih.gov/pubmed/33132503
http://dx.doi.org/10.2337/cd20-0014

Ejemplares similares